ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 22-01-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care 1.41 8.46 52.35 12.53 6.53 14.93

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 60.21 19.88 12.88 2.02 4,383.33
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 60.98 14.34 7.38 2.25 1,575.33
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 57.95 15.04 9.41 2.80 649.26
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 56.47 17.94 8.92 2.63 419.33

Fund Holdings as on 31-December-2020

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Dr. Reddy's Laboratories Ltd. $$

  • TREPS

  • Alkem Laboratories Ltd.

  • IPCA Laboratories Ltd.

  • Tata Chemicals Ltd.

  • Divi's Laboratories Ltd.

  • Lupin Ltd.

  • Cadila Healthcare Ltd.

  • Sanofi India Ltd.

  • Indoco Remedies Ltd.

  • Torrent Pharmaceuticals Ltd.

  • J.B.Chemicals & Pharmaceuticals Ltd.

  • Biocon Ltd.

  • Fortis Healthcare Ltd.

  • Aster DM Healthcare Ltd.

  • Narayana Hrudayalaya Ltd.

  • Syngene International Ltd.

  • SBI Life Insurance Company Ltd.

  • Natco Pharma Ltd.

  • Neuland Laboratories Ltd.

  • Gufic Biosciences Ltd.

  • Dishman Carbogen Amcis Ltd.

  • Healthcare Global Enterprises Ltd.

  • Laurus Labs Ltd.

  • Panacea Biotec Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • 364 Days Treasury Bills

  • Gland Pharma Ltd.

  • 364 Days Treasury Bills

  • Ravinder Heights Ltd.

  • Cash Margin - Derivatives

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Insurance

  • Construction - Real Estate

View More

Fund Manager

  • Cash

  • Equity

  • Sov

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹2,159.31 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended down ₹-0.22(-1.24%)yesterday to ₹17.52.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Priyanka Khandelwal and Dharmesh Kakkad.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100